These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25926795)

  • 1. The therapeutic potential of orphan GPCRs, GPR35 and GPR55.
    Shore DM; Reggio PH
    Front Pharmacol; 2015; 6():69. PubMed ID: 25926795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
    Zhao P; Abood ME
    Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
    Guo YJ; Zhou YJ; Yang XL; Shao ZM; Ou ZL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1159-1167. PubMed ID: 28943434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Sharir H; Shore DM; Hurst DP; Lynch DL; Madrigal KE; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak LS; Croatt MP; Abood ME; Reggio PH
    Biochemistry; 2013 Dec; 52(52):9456-69. PubMed ID: 24274581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Non-CB
    Morales P; Reggio PH
    Cannabis Cannabinoid Res; 2017; 2(1):265-273. PubMed ID: 29098189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors.
    Irving A; Abdulrazzaq G; Chan SLF; Penman J; Harvey J; Alexander SPH
    Adv Pharmacol; 2017; 80():223-247. PubMed ID: 28826536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orphan receptor GPR55 is a novel cannabinoid receptor.
    Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
    Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From orphan to oncogene: The role of GPR35 in cancer and immune modulation.
    Takkar S; Sharma G; Kaushal JB; Abdullah KM; Batra SK; Siddiqui JA
    Cytokine Growth Factor Rev; 2024 Jun; 77():56-66. PubMed ID: 38514303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of orphan G protein-coupled receptors in the modulation of pain: A review.
    Nourbakhsh F; Atabaki R; Roohbakhsh A
    Life Sci; 2018 Nov; 212():59-69. PubMed ID: 30236869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.
    Maravillas-Montero JL; Burkhardt AM; Hevezi PA; Carnevale CD; Smit MJ; Zlotnik A
    J Immunol; 2015 Jan; 194(1):29-33. PubMed ID: 25411203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
    Yao H; Lv Y; Bai X; Yu Z; Liu X
    Oncol Lett; 2020 Sep; 20(3):2711-2720. PubMed ID: 32782587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
    Park SJ; Lee SJ; Nam SY; Im DS
    Br J Pharmacol; 2018 Jan; 175(1):154-161. PubMed ID: 29068046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR55: from orphan to metabolic regulator?
    Liu B; Song S; Jones PM; Persaud SJ
    Pharmacol Ther; 2015 Jan; 145():35-42. PubMed ID: 24972076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.